Lidonostrum (Lidocaine)

Lidocaine blocks voltage‑gated sodium channels on peripheral nerves, preventing the influx of sodium ions that is necessary for the generation and propagation of action potentials. This interruption stops nerve signal transmission, resulting in reversible loss of sensation at the site of application.

The appropriate dose of Lidonostrum is determined by the prescribing healthcare professional based on the specific indication, the size of the treatment area, patient age, and other clinical factors. No fixed regimen is provided; the prescriber sets the amount and frequency of application.

Safety data for lidocaine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss any concerns with the patient.

To order Lidonostrum, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lidonostrum (lidocaine) offers rapid onset and moderate duration of action, making it suitable for many superficial procedures. Compared with benzocaine, lidocaine provides deeper penetration and less allergic potential, while agents like prilocaine may have a slower onset. Choice depends on the procedure, required depth of anesthesia and patient tolerance.

Lidonostrum should be stored below 25 °C in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid freezing. Ensure the packaging remains sealed until use to maintain product integrity.

Lidonostrum is applied topically to the target area. For skin use, a thin layer is spread over the intended site and allowed to absorb. For nasal or oral mucosa, a small amount is placed on the mucous membrane using a swab or applicator, following the prescriber's instructions.

The most serious risks include systemic toxicity such as seizures, cardiac arrhythmias, and severe allergic reactions like anaphylaxis. Methemoglobinemia and rare severe skin reactions (e.g., Stevens‑Johnson syndrome) may also occur, especially with extensive mucosal application or overdose.

Lidonostrum should be avoided in individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics. Patients with severe heart block, significant conduction abnormalities, or those taking other sodium‑channel blocking drugs should use it only under strict medical supervision.